Level V involvement in patients with early T-stage, node-positive oropharyngeal carcinoma

Kavita M. Pattani, Joseph Califano, Giuseppe Sanguineti

Research output: Contribution to journalArticle

Abstract

Objectives/Hypothesis: To assess the risk of level V nodal involvement for early T-stage and node positive oropharyngeal squamous cell carcinoma (ORO-SCC). Methods: Retrospective analysis performed on patients with ORO-SCC and clinically positive lymph nodes who had undergone upfront elective dissection of level V before definitive chemoradiotherapy. Pathological data collected and prevalence of involvement of level V determined. Results: A total of 119 patients had level V dissection. The prevalence of pathologically positive lymph nodes in level V was 3.4% (4/119). Moreover, it was observed only in the presence of pathological involvement of multiple other nodal levels (4/52 patients, 7.7% vs. 0/67 in patients with a single nodal station involved, χ2 P = .02). Conclusions: Subclinical involvement of level V in ORO-SCC is rare, especially in the presence of disease confined to a single nodal level. The present data do not support its dissection after primary chemoradiotherapy.

Original languageEnglish (US)
Pages (from-to)2165-2169
Number of pages5
JournalLaryngoscope
Volume119
Issue number11
DOIs
StatePublished - Nov 2009

Fingerprint

Carcinoma
Dissection
Squamous Cell Carcinoma
Chemoradiotherapy
Lymph Nodes

Keywords

  • Level V
  • Neck dissection
  • Oropharyngeal cancer

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Level V involvement in patients with early T-stage, node-positive oropharyngeal carcinoma. / Pattani, Kavita M.; Califano, Joseph; Sanguineti, Giuseppe.

In: Laryngoscope, Vol. 119, No. 11, 11.2009, p. 2165-2169.

Research output: Contribution to journalArticle

Pattani, Kavita M. ; Califano, Joseph ; Sanguineti, Giuseppe. / Level V involvement in patients with early T-stage, node-positive oropharyngeal carcinoma. In: Laryngoscope. 2009 ; Vol. 119, No. 11. pp. 2165-2169.
@article{71f91d4c46ba406d958f3f672dda87a2,
title = "Level V involvement in patients with early T-stage, node-positive oropharyngeal carcinoma",
abstract = "Objectives/Hypothesis: To assess the risk of level V nodal involvement for early T-stage and node positive oropharyngeal squamous cell carcinoma (ORO-SCC). Methods: Retrospective analysis performed on patients with ORO-SCC and clinically positive lymph nodes who had undergone upfront elective dissection of level V before definitive chemoradiotherapy. Pathological data collected and prevalence of involvement of level V determined. Results: A total of 119 patients had level V dissection. The prevalence of pathologically positive lymph nodes in level V was 3.4{\%} (4/119). Moreover, it was observed only in the presence of pathological involvement of multiple other nodal levels (4/52 patients, 7.7{\%} vs. 0/67 in patients with a single nodal station involved, χ2 P = .02). Conclusions: Subclinical involvement of level V in ORO-SCC is rare, especially in the presence of disease confined to a single nodal level. The present data do not support its dissection after primary chemoradiotherapy.",
keywords = "Level V, Neck dissection, Oropharyngeal cancer",
author = "Pattani, {Kavita M.} and Joseph Califano and Giuseppe Sanguineti",
year = "2009",
month = "11",
doi = "10.1002/lary.20616",
language = "English (US)",
volume = "119",
pages = "2165--2169",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Level V involvement in patients with early T-stage, node-positive oropharyngeal carcinoma

AU - Pattani, Kavita M.

AU - Califano, Joseph

AU - Sanguineti, Giuseppe

PY - 2009/11

Y1 - 2009/11

N2 - Objectives/Hypothesis: To assess the risk of level V nodal involvement for early T-stage and node positive oropharyngeal squamous cell carcinoma (ORO-SCC). Methods: Retrospective analysis performed on patients with ORO-SCC and clinically positive lymph nodes who had undergone upfront elective dissection of level V before definitive chemoradiotherapy. Pathological data collected and prevalence of involvement of level V determined. Results: A total of 119 patients had level V dissection. The prevalence of pathologically positive lymph nodes in level V was 3.4% (4/119). Moreover, it was observed only in the presence of pathological involvement of multiple other nodal levels (4/52 patients, 7.7% vs. 0/67 in patients with a single nodal station involved, χ2 P = .02). Conclusions: Subclinical involvement of level V in ORO-SCC is rare, especially in the presence of disease confined to a single nodal level. The present data do not support its dissection after primary chemoradiotherapy.

AB - Objectives/Hypothesis: To assess the risk of level V nodal involvement for early T-stage and node positive oropharyngeal squamous cell carcinoma (ORO-SCC). Methods: Retrospective analysis performed on patients with ORO-SCC and clinically positive lymph nodes who had undergone upfront elective dissection of level V before definitive chemoradiotherapy. Pathological data collected and prevalence of involvement of level V determined. Results: A total of 119 patients had level V dissection. The prevalence of pathologically positive lymph nodes in level V was 3.4% (4/119). Moreover, it was observed only in the presence of pathological involvement of multiple other nodal levels (4/52 patients, 7.7% vs. 0/67 in patients with a single nodal station involved, χ2 P = .02). Conclusions: Subclinical involvement of level V in ORO-SCC is rare, especially in the presence of disease confined to a single nodal level. The present data do not support its dissection after primary chemoradiotherapy.

KW - Level V

KW - Neck dissection

KW - Oropharyngeal cancer

UR - http://www.scopus.com/inward/record.url?scp=73449135174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449135174&partnerID=8YFLogxK

U2 - 10.1002/lary.20616

DO - 10.1002/lary.20616

M3 - Article

VL - 119

SP - 2165

EP - 2169

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 11

ER -